GlucoTrack Inc (GCTK)
0.50
+0.01
(+2.00%)
USD |
NASDAQ |
May 17, 16:00
0.50
0.00 (0.00%)
After-Hours: 20:00
GlucoTrack Cash from Financing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 8.73M |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 13.01M |
| December 31, 2019 | -0.0006M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 3.442M |
| March 31, 2019 | 0.7561M |
| December 31, 2018 | 0.256M |
| September 30, 2018 | 2.287M |
| June 30, 2018 | 0.7208M |
| March 31, 2018 | 1.698M |
| December 31, 2017 | 0.3767M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.8538M |
| June 30, 2017 | 1.921M |
| March 31, 2017 | 2.599M |
| December 31, 2016 | 0.4329M |
| September 30, 2016 | 0.7579M |
| June 30, 2016 | 3.718M |
| March 31, 2016 | 0.0274M |
| December 31, 2015 | 0.0314M |
| September 30, 2015 | -0.0053M |
| June 30, 2015 | -0.0265M |
| March 31, 2015 | -0.4605M |
| December 31, 2014 | 2.430M |
| September 30, 2014 | 4.728M |
| June 30, 2014 | -0.1164M |
| March 31, 2014 | -0.0689M |
| December 31, 2013 | -0.1858M |
| September 30, 2013 | -0.0874M |
| June 30, 2013 | -0.0701M |
| March 31, 2013 | 5.399M |
| December 31, 2012 | 0.9025M |
| September 30, 2012 | 0.051M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.0003M |
| September 30, 2011 | 1.466M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.0006M
Minimum
Dec 2019
13.01M
Maximum
Mar 2020
1.937M
Average
--
Median
Sep 2019
Cash from Financing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 166.33M |
| Retractable Technologies Inc | -0.1364M |
| Xtant Medical Holdings Inc | 5.179M |
| Asensus Surgical Inc | 0.811M |
| Catheter Precision Inc | -0.11M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.411M |
| Free Cash Flow | -6.558M |
| Free Cash Flow Per Share (Quarterly) | -0.1051 |
| Free Cash Flow Yield | -63.23% |